Hotline:
+ 49 (0) 2204 2918806

Market studies for category Healthcare

Items 1 to 10 of 202 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 21
  1. Net price*
    Year
  2. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Dengue Global Clinical Trials Review, H1, 2013

    GlobalData
    91 pages
    Introduction GlobalData's clinical trial report, “Dengue Global Clinical Trials Review, H1, 2013" provides data on the Dengue clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dengue. It includes an overview of the trial numbers and their recruitment status as per the site of
    Englisch | Report | SKU: 329571
  3. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Xgeva (Prostate Cancer) - Forecast and Market Analysis to 2022

    GlobalData
    49 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, “Xgeva (Prostate Cancer) - Forecast and Market Analysis to 2022”. The recent approvals of second-line metastatic castration-resistant prostate cancer (mCRPC) therapies like J&J’s Zytiga (abiraterone acetate) and Medivation/Astellas’ Xtandi (enzalutami
    Englisch | Report | SKU: 330286
  4. $6,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Fycompa (Epilepsy) - Forecast and Market Analysis to 2022

    GlobalData
    51 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, “Fycompa (Epilepsy) - Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reductio
    Englisch | Report | SKU: 330450
  5. $1,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    64th American Academy of Neurology, 2012 - Post-conference Review and Analysis

    GlobalData
    20 pages
    Introduction GlobalData, the industry analysis specialist, has released its new conference alerts, “64th American Academy of Neurology, 2012 - Post-conference Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies and new disease management techniques.The annual symposiu
    Englisch | Report | SKU: 325431
  6. $1,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Healthcare, Regulatory and Reimbursement Landscape - Egypt

    GlobalData
    171 pages
    Introduction GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - Egypt”. The report is an essential source of information and analysis on Egypt’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and p
    Englisch | Report | SKU: 330254
  7. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Mitral Regurgitation Global Clinical Trials Review, H1, 2013

    GlobalData
    75 pages
    Introduction GlobalData's clinical trial report, “Mitral Regurgitation Global Clinical Trials Review, H1, 2013" provides data on the Mitral Regurgitation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mitral Regurgitation. It includes an overview of the trial numbers and t
    Englisch | Report | SKU: 330318
  8. $4,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Remote Patient Monitoring - Pipeline Review, 2015

    GlobalData
    112 pages
    GlobalData's Medical Devices sector report, “Remote Patient Monitoring - Pipeline Review, 2015" provides an overview of Remote Patient Monitoring currently in pipeline stage.The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report review
    Englisch | Zukunftsanalyse | SKU: 987680113
  9. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Cerebral Aneurysms Global Clinical Trials Review, H1, 2013

    GlobalData
    57 pages
    Introduction GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H1, 2013" provides data on the Cerebral Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Aneurysms. It includes an overview of the trial numbers and their r
    Englisch | Report | SKU: 329576
  10. $4,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022

    GlobalData
    135 pages
    Introduction GlobalData has released its new Country report, “PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The
    Englisch | Report | SKU: 330291
  11. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Aortic Aneurysm Global Clinical Trials Review, H1, 2013

    GlobalData
    79 pages
    Introduction GlobalData's clinical trial report, “Aortic Aneurysm Global Clinical Trials Review, H1, 2013" provides data on the Aortic Aneurysm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aortic Aneurysm. It includes an overview of the trial numbers and their recruitmen
    Englisch | Report | SKU: 330455

Items 1 to 10 of 202 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 21